Literature DB >> 12403887

Pneumonitis induced by rifampicin.

N Kunichika1, N Miyahara, K Kotani, H Takeyama, M Harada, M Tanimoto.   

Abstract

An 81-year-old man was admitted to hospital with pulmonary Mycobacterium tuberculosis infection and was treated with rifampicin (RFP), isoniazid (INH), and ethambutol (EB). On day 9 he developed fever and dyspnoea. Chest radiographs showed new infiltration shadows in the right lung. Bronchoalveolar lavage (BAL) was performed and increased numbers of lymphocytes were recovered. Drug induced pneumonitis was suspected so the antituberculous regimen was discontinued and methylprednisolone was administered. The symptoms and infiltration shadows improved. INH and EB were reintroduced without any recurrence of the abnormal shadows. T cell subsets in the BAL fluid and a positive lymphocyte stimulation test for RFP suggest that RFP induced pneumonitis may be related to a complex immunological response.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12403887      PMCID: PMC1746231          DOI: 10.1136/thorax.57.11.1000

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  5 in total

1.  Isoniazid and pulmonary fibrosis.

Authors:  Chae Uk Chung; Dong Il Park; Choong Sik Lee; Sung Soo Jung
Journal:  Chin Med J (Engl)       Date:  2015-03-05       Impact factor: 2.628

2.  Amoxicillin-Induced Eosinophilic Pneumonia with Granulomatous Reaction: Discrepancy between Drug-Induced Lymphocyte Stimulation Test Findings and the Provocation Drug Test.

Authors:  Osamu Matsuno; Ryuichi Takenaka; Masaru Ando; Eishi Miyazaki; Tosihide Kumamoto
Journal:  Allergy Asthma Clin Immunol       Date:  2007-06-15       Impact factor: 3.406

3.  Bilateral Tuberculous Pleurisy with Subsequent Upper Lobe Predominant Pulmonary Fibrosis Mimicking Pleuroparenchymal Fibroelastosis.

Authors:  Takako Kawaguchi; Keishi Oda; Takashi Kido; Toshinori Kawanami; Yoshinori Kawabata; Kazuhiro Yatera
Journal:  Intern Med       Date:  2017-10-16       Impact factor: 1.271

Review 4.  Hypersensitivity reaction with multi-organ failure following re-exposure to rifampicin: case report and review of the literature including WHO spontaneous safety reports.

Authors:  Lisa Brockhaus; Yasmin Schmid; Anna C Rast; Alexandra E Rätz Bravo; Kathrin Scherer Hofmeier; Anne B Leuppi-Taegtmeyer
Journal:  BMC Pharmacol Toxicol       Date:  2019-02-12       Impact factor: 2.483

5.  Rifampicin-Induced Pneumonitis Mimicking Severe COVID-19 Pneumonia Infection.

Authors:  Fateen Ata; Mousa Shaher Mousa Hussein; Ahmad Y Mismar; Rohit Sharma; Issam A M Bozom; Zeinab Alsiddig Ali Ibrahim; Wanis H Ibrahim
Journal:  Am J Case Rep       Date:  2020-08-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.